Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Current drug metabolism

• Publication date

  2015-11-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/138920021610151210164501PMID 26652254
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibitors and prodrugs targeting CYP1: a novel approach in cancer prevention and therapy.

  2014cited by this paper
• CYP2B6*6 is associated with increased breast cancer risk

  2014cited by this paper
• RETRACTED ARTICLE: CYP1A2 rs762551 polymorphism contributes to risk of lung cancer: A meta-analysis

  2014cited by this paper
• RsaI but not DraI polymorphism in CYP2E1 gene increases the risk of gastrointestinal cancer in Malaysians: a case–control study

  2014cited by this paper
• CYP1A1 gene polymorphisms and smoking status as modifier factors for lung cancer risk.

  2014cited by this paper
• Association of CYP2A6*4 with Susceptibility of Lung Cancer: A Meta-Analysis

  2013cited by this paper
• CYP2E1 T7632A and 9-bp insertion polymorphisms and colorectal cancer risk: a meta-analysis based on 4,592 cases and 5,918 controls

  2013cited by this paper
• CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression

  2013cited by this paper
• Dietary aflatoxin B1 intake, genetic polymorphisms of CYP1A2, CYP2E1, EPHX1, GSTM1, and GSTT1, and gastric cancer risk in Korean

  2013cited by this paper
• Association between CYP2A6 genetic polymorphisms and lung cancer: A meta‐analysis of case–control studies

  2013cited by this paper
• Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.

  2013cited by this paper
• CYP1B1 C4326G polymorphism and susceptibility to cervical cancer in Chinese Han women

  2013cited by this paper
• Cytochrome P450 1A1, 2E1 and GSTM1 gene polymorphisms and susceptibility to colorectal cancer in the Saudi population.

  2013influential reference
• Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco-specific nitrosamine exposure and lower tobacco-specific nitrosamine bioactivation.

  2013cited by this paper
• CYP2E1 and NQO1 genotypes and bladder cancer risk in a Lebanese population.

  2013influential reference
• Polymorphisms in CYP17 and CYP3A4 and prostate cancer in men of African descent

  2013cited by this paper
• MspI and Ile462Val Polymorphisms in CYP1A1 and Overall Cancer Risk: A Meta-Analysis

  2013influential reference
• RETRACTED ARTICLE: CYP2D6 T188C variant is associated with lung cancer risk in the Chinese population

  2013influential reference
• CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis

  2013influential reference
• A review of global cancer burden: Trends, challenges, strategies, and a role for surgeons

  2013cited by this paper
• Meta-analysis of the CYP1A2 -163C>A polymorphism and lung cancer risk.

  2013cited by this paper
• CYP3A4*1B polymorphism and cancer risk: A HuGE review and meta-analysis

  2013cited by this paper
• Role of CYP1A2 polymorphisms in breast cancer risk in women.

  2013cited by this paper
• CYP2A6 deletion polymorphism is associated with decreased susceptibility of lung cancer in Asian smokers: a meta-analysis

  2013cited by this paper
• Quantitative Assessment of the Influence of Cytochrome P450 1A2 Gene Polymorphism and Colorectal Cancer Risk

  2013influential reference
• A regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma

  2013cited by this paper
• CYP1B1 Polymorphisms and Susceptibility to Prostate Cancer: A Meta-Analysis

  2013influential reference
• Current evidence on the relationship between three polymorphisms in the CYP1A2 gene and the risk of cancer

  2013cited by this paper
• Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis

  2013influential reference
• Current evidence on the relationship between CYP1B1 polymorphisms and lung cancer risk: a meta-analysis

  2012cited by this paper
• Glutathione S-transferase M1 and T1, CYP1A2-2467T/delT polymorphisms and non small-cell lung cancer risk in Tunisian sample

  2012cited by this paper
• CYP1B1 Asn453Ser polymorphism and colorectal cancer risk: a meta-analysis.

  2012influential reference
• Role of CYP1A2 polymorphisms on lung cancer risk in a prospective study.

  2012cited by this paper
• CYP1A1 MspI polymorphisms and lung cancer risk: an updated meta-analysis involving 20,209 subjects.

  2012cited by this paper
• Genetic variants of CYP2D6 gene and cancer risk: a HuGE systematic review and meta-analysis.

  2012cited by this paper
• Role of CYP1B1 gene polymorphisms in bladder cancer susceptibility.

  2012cited by this paper
• Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and ovarian cancer risk: a meta-analysis

  2012cited by this paper
• CYP1A2 rs762551 polymorphism contributes to cancer susceptibility: a meta-analysis from 19 case-control studies

  2012cited by this paper
• GSTT1, GSTM1, and CYP1B1 gene polymorphisms and susceptibility to sporadic renal cell cancer.

  2012cited by this paper
• Functional PstI/RsaI Polymorphism in CYP2E1 Is Associated with the Development, Progression and Poor Outcome of Gastric Cancer

  2012cited by this paper
• CYP2E1 RsaI/PstI Polymorphism and Gastric Cancer Susceptibility: Meta-Analyses Based on 24 Case-Control Studies

  2012cited by this paper
• Associations between CYP1A1 and CYP2E1 polymorphisms and susceptibility to esophageal cancer in Chaoshan and Taihang areas of China.

  2012cited by this paper
• Prostate cancer risk and aggressiveness associated with the CYP1B1 4326C/G (Leu432Val) polymorphism: a meta-analysis of 2788 cases and 2968 controls.

  2012cited by this paper
• Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis

  2012cited by this paper
• CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls

  2012cited by this paper
• Cytochrome P450 2E1 RsaI/PstI polymorphism and risk of esophageal cancer: A meta-analysis of 17 case-control studies

  2012cited by this paper
• Effect of CYP2D6 polymorphisms on breast cancer recurrence

  2012cited by this paper
• Docking and QSAR comparative studies of polycyclic aromatic hydrocarbons and other procarcinogen interactions with cytochromes P450 1A1 and 1B1

  2012cited by this paper
• Catechol metabolites of endogenous estrogens induce redox cycling and generate reactive oxygen species in breast epithelial cells.

  2011cited by this paper
• Genetic polymorphisms of metabolic enzymes—CYP1A1, CYP2D6, GSTM1, and GSTT1, and gastric carcinoma susceptibility

  2011cited by this paper
• No association between the CYP1B1 C4326G polymorphism and endometrial cancer risk: a meta-analysis.

  2011cited by this paper
• CYP2E1 Rsa I/Pst I polymorphism contributes to oral cancer susceptibility: a meta-analysis

  2011cited by this paper
• Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan.

  2011influential reference
• Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer

  2011cited by this paper
• Variant alleles of the CYP1B1 gene are associated with colorectal cancer susceptibility

  2010cited by this paper
• The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies

  2010influential reference
• Genetic polymorphism of CYP3A5 in Indian chronic myeloid leukemia patients

  2010cited by this paper
• CYP2D6*4 polymorphisms and breast cancer risk

  2010cited by this paper
• Does race modify the association between CYP1B1 Val432Leu polymorphism and breast cancer risk? A critical appraisal of a recent meta-analysis

  2010cited by this paper
• Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population.

  2010cited by this paper
• Smoking related risk involved in individuals carrying genetic variants of CYP1A1 gene in head and neck cancer.

  2010cited by this paper
• CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen

  2010cited by this paper
• Polymorphisms in CYP2A13 and UGT1A7 genes and head and neck cancer susceptibility in North Indians.

  2010cited by this paper
• CYP1A2 polymorphisms, occupational and environmental exposures and risk of bladder cancer

  2010cited by this paper
• Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis

  2010cited by this paper
• CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis.

  2010cited by this paper
• The CYP1B1 Leu432Val polymorphism contributes to lung cancer risk: evidence from 6501 subjects.

  2010cited by this paper
• CYP1A1 polymorphisms and risk of lung cancer in the ethnic Kashmiri population.

  2009cited by this paper
• Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention

  2009influential reference
• Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of stomach cancer: a hospital-based case-control study in Japan

  2009influential reference
• Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population.

  2009cited by this paper
• CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences.

  2009influential reference
• CYP1A1/2 haplotypes and lung cancer and assessment of confounding by population stratification.

  2009cited by this paper
• Genetic Polymorphism of Metabolic Enzymes P450 (CYP) as a Susceptibility Factor for Drug Response, Toxicity, and Cancer Risk

  2009cited by this paper
• CYP1A2 genetic polymorphisms and adenocarcinoma lung cancer risk in the Tunisian population.

  2009cited by this paper
• Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of colorectal cancer: A hospital-based case-control study in Japan

  2009cited by this paper
• Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.

  2009influential reference
• CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population

  2008cited by this paper
• Aberrant Splicing Caused by Single Nucleotide Polymorphism c.516G>T [Q172H], a Marker of CYP2B6*6, Is Responsible for Decreased Expression and Activity of CYP2B6 in Liver

  2008cited by this paper
• Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population.

  2007cited by this paper
• Polymorphisms of GSTP 1 and GSTT 1 , but not of CYP 2 A 6 , CYP 2 E 1 or GSTM 1 , modify the risk for esophageal cancer in a western population

  2007cited by this paper
• Mouse lung CYP 1 A 1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo [ 4 , 5b ] pyridine ( PhIP )

  2007cited by this paper
• An association of CYP2A6 genotype and smoking topography.

  2007cited by this paper
• CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: A meta-analysis of the literature.

  2007cited by this paper
• Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene.

  2006cited by this paper
• In vivo evaluation of coumarin and nicotine as probe drugs to predict the metabolic capacity of CYP2A6 due to genetic polymorphism in Thais.

  2006cited by this paper
• Mouse lung CYP1A1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).

  2006cited by this paper
• Xenobiotic-metabolizing enzymes in human lung.

  2006cited by this paper
• Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction

  2006influential reference
• Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons.

  2006cited by this paper
• Rapid detection of common cytochrome P450 2D6 alleles in Caucasians.

  2006influential reference
• Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract

  2006cited by this paper
• Oral Benzo[a]pyrene in Cyp1 Knockout Mouse Lines: CYP1A1 Important in Detoxication, CYP1B1 Metabolism Required for Immune Damage Independent of Total-Body Burden and Clearance Rate

  2006cited by this paper
• Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice humanized for CYP1A1 and CYP1A2.

  2005cited by this paper
• CYP2A13 genetic polymorphism in French Caucasian, Gabonese and Tunisian populations

  2005cited by this paper
• Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N'-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine.

  2005cited by this paper
• Proteasomal Degradation of Human CYP1B1: Effect of the Asn453Ser Polymorphism on the Post-Translational Regulation of CYP1B1 Expression

  2005cited by this paper
• CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.

  2005cited by this paper
• BMC Clinical Pharmacology BioMed Central Research article Distribution of cytochrome P450 2C, 2E1, 3A4, and 3A5 in human

  2005cited by this paper
• Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition.

  2005cited by this paper

• The role of cytochrome P4502E1 in ethanol mediated diseases: a narrative update.

  2025cites this paper
• Development of a TK6-derived cell line expressing four human cytochrome P450s for genotoxicity testing.

  2025cites this paper
• Advances in Cytochrome P450 in Tumor Therapy

  2025cites this paper
• Reimagining Dearomatization: Arenophile-Mediated Single-Atom Insertions and π-Extensions.

  2025cites this paper
• Inhibitory Effect of Two Carbonic Anhydrases Inhibitors on the Activity of Major Cytochrome P450 Enzymes

  2024cites this paper
• Toxicity assessment of dioxins and their transformation by-products from inferred degradation pathways.

  2024cites this paper
• Veratrum nigrum L.: A comprehensive review of ethnopharmacology, phytochemistry, pharmacology, pharmacokinetics and metabolism, toxicity, and incompatibility.

  2024cites this paper
• Alterations in histopathology and stress-associated gene expression induced by infection with Prohemistomum vivax encysted metacercariae in Nile tilapia

  2024cites this paper
• Assessment of the association of the CYP1A1 gene RS1048943 polymorphism in the colorectal cancer: a meta-analysis

  2024cites this paper
• Apiole, an important constituent of parsley, is a mixed-type inhibitor of the CYP1A subfamily.

  2024cites this paper
• Effects of Berberis vulgaris, and its active constituent berberine on cytochrome P450: a review

  2024cites this paper
• Decoding the Role of CYP450 Enzymes in Metabolism and Disease: A Comprehensive Review

  2024cites this paper
• Transgenic Zebrafish Expressing Rat Cytochrome P450 2E1 (CYP2E1): Augmentation of Acetaminophen-Induced Toxicity in the Liver and Retina

  2023influential citation
• Design, Synthesis, and Biological Studies of Flavone-Based Esters and Acids as Potential P450 2A6 Inhibitors

  2023cites this paper
• Construction of Humanized CYP1A2 Rats Using CRISPR/CRISPR-Associated Protein 9 to Promote Drug Metabolism and Pharmacokinetic Research

  2023cites this paper
• Lower overall survival in male patients with advanced disease undergoing allogeneic hematopoietic stem cell transplantation is associated with CYP1B1 Leu432Val polymorphism

  2023cites this paper
• Special Section on New and Emerging Areas and Technologies in Drug Metabolism and Disposition, Part I — Minireview Fluorescence-Based High-Throughput Assays for Investigating Cytochrome P450 Enzyme-Mediated Drug – Drug Interactions

  2023cites this paper
• Glycidamide-induced hypermutation in yeast single-stranded DNA reveals a ubiquitous clock-like mutational motif in humans.

  2023cites this paper
• Fluorescence-Based High-Throughput Assays for Investigating Cytochrome P450 Enzyme-Mediated Drug–Drug Interactions

  2023cites this paper
• CYP1A inhibitors: Recent progress, current challenges, and future perspectives

  2023cites this paper
• Risk assessment of N‐nitrosamines in food

  2023cites this paper
• Augmentation of Pectoral Fin Teratogenicity by Thalidomide in Human Cytochrome P450 3A-Expressing Zebrafish

  2023cites this paper
• The Role of Cytochrome P450 Enzymes in COVID-19 Pathogenesis and Therapy

  2022cites this paper
• Evidence-based capacity of natural cytochrome enzyme inhibitors to increase the effectivity of antineoplastic drugs

  2022cites this paper
• The inhibition of tamoxifen on UGT2B gene expression and enzyme activity in rat liver contribute to the estrogen homeostasis dysregulation

  2022cites this paper
• Interaction of cytochrome P450s with environmental risk factors increases their expression and risk to head and neck cancer

  2022cites this paper
• The Fagerström and AUDIT Tests as Probable Screening Tools in Oral Cancer and Their Correlation with CYP1A1, GSTM1, GSTP1, and GSTT1 Gene Expression

  2022cites this paper
• Cytochromes P450: Role in Carcinogenesis and Relevance to Cancers.

  2022cites this paper
• Independent and Interactive Effect of CYPs and GSTs Genetic Variants and Tobacco Smoking on the Risk of Non-Small Cell Lung Carcinoma.

  2021cites this paper
• The Central Role of Cytochrome P450 in Xenobiotic Metabolism—A Brief Review on a Fascinating Enzyme Family

  2021cites this paper
• Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity

  2021cites this paper
• Mango (Mangifera indica L.) Polyphenols: Anti-Inflammatory Intestinal Microbial Health Benefits, and Associated Mechanisms of Actions

  2021cites this paper
• Identification of CYP 2A6 inhibitors in an effort to mitigate the harmful effects of the phytochemical nicotine

  2021cites this paper
• RNA Sequencing of Early-Stage Gastric Adenocarcinoma Reveals Multiple Activated Pathways and Novel Long Non-Coding RNAs in Patient Tissue Samples.

  2021cites this paper
• A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma

  2021cites this paper
• Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes

  2021cites this paper
• Xenobiotic Metabolic Enzymes: Bioactivation and Antioxidant Defense

  2020cites this paper
• Consumption of baby kale increased cytochrome P450 1A2 (CYP1A2) activity and influenced bilirubin metabolism in a randomized clinical trial

  2020cites this paper
• The Multifarious Link between Cytochrome P450s and Cancer

  2020cites this paper
• Association between CYP2B6 polymorphism and acute leukemia in a Han population of Northwest China

  2020cites this paper
• Enzyme Polymorphisms Affecting Xenobiotic Toxicity

  2020cites this paper
• Epigenetic Regulation of Differentially Expressed Drug-Metabolizing Enzymes in Cancer

  2020cites this paper
• Genotoxic activities of wastewater after ozonation and activated carbon filtration: Different effects in liver-derived cells and bacterial indicators.

  2020cites this paper
• The activation of procarcinogens by CYP1A1/1B1 and related chemopreventive agents: A review.

  2020cites this paper
• Involvement of cytochrome P450 enzymes in inflammation and cancer: a review

  2020cites this paper
• Computational study on the metabolic activation mechanism of PeCDD by Cytochrome P450 1A1.

  2020cites this paper
• Anti-Tumor Activity of Hypericum perforatum L. and Hyperforin through Modulation of Inflammatory Signaling, ROS Generation and Proton Dynamics

  2020cites this paper
• Cytochrome P450 1B1*2 Gene Polymorphism in a Turkish Population

  2019cites this paper
• Evaluating metronidazole as a novel, safe CYP2A6 phenotyping probe in healthy adults

  2019cites this paper
• Associations of CYP1 polymorphisms with risk of prostate cancer: an updated meta-analysis

  2019cites this paper
• High-protein diets for weight management: Interactions with the intestinal microbiota and consequences for gut health. A position paper by the my new gut study group.

  2019cites this paper
• 基于TCGA数据库的中央型与周围型肺鳞癌基因表达差异性研究

  2019cites this paper
• Genotoxic Assays for Measuring P450 Activation of Chemical Mutagens

  2019cites this paper
• Co-carcinogenic effects of vitamin E in prostate

  2019cites this paper
• Gene polymorphism of cytochrome P450 significantly affects lung cancer susceptibility

  2019cites this paper
• Plasma exosomes exacerbate alcohol- and acetaminophen-induced toxicity via CYP2E1 pathway

  2019cites this paper
• Detection the Genetic Variation for GSTM1, GSTT1 Genes in Smokers by Multiplex-PCR Technique

  2018cites this paper
• Interconnexion du métabolisme cellulaire et de la voie de glucuronidation

  2018cites this paper
• 3. Study on Component Analysis of Extracts from Pharmaceutical Products and Composition and Accounting of Drug Cost

  2018cites this paper
• Pharmacological analysis of dexmedetomidine hydrochloride in pediatric anesthesia during magnetic resonance imaging.

  2018cites this paper
• Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis

  2018cites this paper
• Risk for animal and human health related to the presence of dioxins and dioxin‐like PCBs in feed and food

  2018cites this paper
• Resveratrol: An overview of its anti‐cancer mechanisms

  2018cites this paper
• The roles of cytochrome P450 and P-glycoprotein in the pharmacokinetics of florfenicol in chickens.

  2018cites this paper
• Analysis of the role of rs2031920 and rs3813867 polymorphisms within the cytochrome P450 2E1 gene in the risk of squamous cell carcinoma

  2018cites this paper
• Enzyme‐inducing effects of berberine on cytochrome P450 1A2 in vitro and in vivo

  2017cites this paper
• Characterization of Phase I and Phase II Hepatic Metabolism and Reactive Intermediates of Larrea nitida Cav. and Its Lignan Compounds

  2017cites this paper
• Disturbed testicular expression of the estrogen‐metabolizing enzymes CYP1A1 and COMT in infertile men with primary spermatogenic failure: possible negative implications on Sertoli cells

  2017cites this paper
• Effects of ambient PM2.5 and 9-nitroanthracene on DNA damage and repair, oxidative stress and metabolic enzymes in the lungs of rats.

  2017cites this paper
• The effect analysis of CYP2D6 gene polymorphism in the toremifene and tamoxifen treatment in patient with breast cancer.

  2017cites this paper
• DNA damage and repair, oxidative stress and metabolism biomarker responses in lungs of rats exposed to ambient atmospheric 1-nitropyrene.

  2017cites this paper
• Hepatotoxicity in Rats Induced by Aqueous Extract of Polygoni Multiflori Radix, Root of Polygonum multiflorum Related to the Activity Inhibition of CYP1A2 or CYP2E1

  2017cites this paper
• 2-amino-1-methyl-6-phenylimidazo(4,5-b) pyridine (PhIP) induces gene expression changes in JAK/STAT and MAPK pathways related to inflammation, diabetes and cancer

  2016cites this paper
• Diabetes and cancer

  2016cites this paper
• Roles of defective ALDH2 polymorphism on liver protection and cancer development

  2016cites this paper
• Associations between CYP1A1 rs1048943 A > G and rs4646903 T > C genetic variations and colorectal cancer risk: Proof from 26 case-control studies

  2016cites this paper
• Association of CYP 1 A 1 gene polymorphism and susceptibility to lung cancer : a case-control study

  2016cites this paper
• Genetic variability of CYP2C9*2 and CYP2C9*3 in seven indigenous groups from Mexico.

  2016cites this paper
• Editorial: Role of Drug Metabolism and its Mediated DDI in Drug Efficacy and Safety Part 2.

  2015cites this paper